Abivax Financial Statements From 2010 to 2024
| ABVX Stock | EUR 7.95 0.26 3.38% |
Check Abivax SA financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Abivax SA's main balance sheet or income statement drivers, such as , as well as many indicators such as . Abivax financial statements analysis is a perfect complement when working with Abivax SA Valuation or Volatility modules.
Abivax |
Abivax SA Company Shares Outstanding Analysis
Abivax SA's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Abivax SA Shares Outstanding | 42.32 M |
Most of Abivax SA's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Abivax SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Abivax SA has 42.32 M of shares currently outstending. This is 76.56% lower than that of the Biotechnology sector and 60.4% lower than that of the Health Care industry. The shares outstanding for all France stocks is 92.6% higher than that of the company.
Abivax SA Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Abivax SA's current stock value. Our valuation model uses many indicators to compare Abivax SA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Abivax SA competition to find correlations between indicators driving Abivax SA's intrinsic value. More Info.Abivax SA is rated third in return on equity category among its peers. It also is rated third in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Abivax SA by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Abivax SA's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Abivax SA Financial Statements
Abivax SA stakeholders use historical fundamental indicators, such as Abivax SA's revenue or net income, to determine how well the company is positioned to perform in the future. Although Abivax SA investors may analyze each financial statement separately, they are all interrelated. For example, changes in Abivax SA's assets and liabilities are reflected in the revenues and expenses on Abivax SA's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Abivax SA. Please read more on our technical analysis and fundamental analysis pages.
ABIVAX Socit Anonyme, a biotechnology company, develops, markets, and commercializes anti-viral therapies and therapeutic vaccines for the treatment of infectious diseases in Asia and Latin America. The company was incorporated in 2013 and is headquartered in Paris, France. ABIVAX is traded on Paris Stock Exchange in France.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Abivax Stock
Abivax SA financial ratios help investors to determine whether Abivax Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Abivax with respect to the benefits of owning Abivax SA security.